Showing results (141-150 of 315) with videos related to
Sort By:
Pageof 32
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1993
Galaptin and galaptin-binding glycoconjugates in serum and effusions of carcinoma patientsH J Allen, A Sharma, H Ahmed, et al.International Journal of Radiation Oncology, Biology, Physics|May 1, 1997
Excellent long-term survival and absence of vaginal recurrences in 332 patients with low-risk stage I endometrial adenocarcinoma treated with hysterectomy and vaginal brachytherapy without formal staging lymph node sampling: report of a prospective trialG H Eltabbakh, M S Piver, R E Hempling, et al.Journal of Surgical Oncology|August 1, 1988
Effect of adjuvant chemotherapy on time to recurrence and survival of stage I uterine sarcomasM S Piver, S B Lele, D L Marchetti, et al.Gynecologic Oncology|February 18, 1999
Effects of IL-12 on human ovarian tumors engrafted into SCID miceD F Silver, R E Hempling, M S Piver, et al.Gynecologic Oncology|May 8, 1998
Five-year survival after second-line cisplatin-based intraperitoneal chemotherapy for advanced ovarian cancerF O Recio, M S Piver, R E Hempling, et al.Gynecologic Oncology|December 1, 1992
A prospective trial of progesterone therapy for malignant peritoneal cytology in patients with endometrial carcinomaM S Piver, F O Recio, T R Baker, et al.Gynecologic Oncology|December 22, 1999
First-line chemotherapy with paclitaxel and platinum for advanced and recurrent cancer of the cervix--a phase II studyM S Piver, S A Ghamande, G H Eltabbakh, et al.Gynecologic Oncology|November 1, 1995
Cisplatin, adriamycin, etoposide, megestrol acetate versus melphalan, 5-fluorouracil, medroxyprogesterone acetate in the treatment of endometrial carcinomaT L Cornelison, T R Baker, M S Piver, et al.American Journal of Clinical Oncology|October 22, 1998
Progesterone receptor status is a significant prognostic variable of progression-free survival in advanced epithelial ovarian cancerR E Hempling, M S Piver, G H Eltabbakh, et al.American Journal of Obstetrics and Gynecology|October 1, 1979
Postirradiation squamous cell carcinoma in situ of the vagina: treatment by topical 20 percent 5-fluorouracil creamM S Piver, J J Barlow, Y Tsukada, et al.Pageof 32